Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine in Chronic Kid's (KiCK) Pain
NCT01755169Phase 2Terminated
- Sponsor
- Medical University of South Carolina
- Start
- Jan 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ketamine in chronic pain (4 arms), sponsored by Medical University of South Carolina. Primary endpoint: Dose Limiting Toxicity at 2 weeks. Started Jan 2013; status: terminated.
02
Drugs
ketamine
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT01755169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01755169.